Pacific Biosciences of California Inc (PACB) is up Wednesday morning, with the stock climbing 1.04% in pre-market trading to 8.72.
PACB's short-term technical score of 58 indicates that the stock has traded more bullishly over the last month than 58% of stocks on the market. In the Medical Devices industry, which ranks 132 out of 146 industries, Pacific Biosciences of California Inc ranks higher than 74% of stocks.
Pacific Biosciences of California Inc has risen 21.38% over the past month, closing at $5.97 on November 1. During this period of time, the stock fell as low as $5.97 and as high as $8.72. PACB has an average analyst recommendation of Strong Buy. The company has an average price target of $12.55.
PACB has an Overall Score of 52. Find out what this means to you and get the rest of the rankings on PACB!
Pacific Biosciences of California Inc has a Long-Term Technical rank of 52. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 48% of the market scoring higher. In the Medical Devices industry which is number 119 by this metric, PACB ranks better than 119% of stocks.
